Literature DB >> 12197872

Smallpox--eradicated, but a growing terror threat.

A Tegnell1, B Wahren, F Elgh.   

Abstract

Smallpox is a disease that followed humanity for thousands of years up until 30 years ago. It was possible to eradicate, because an effective live vaccine from crossreacting vaccinia could be developed. Twenty years have passed since vaccinations stopped and very few people are protected against the disease today. Variola today has become an object of discussion due to the possibility that it can be used as a bioweapon. Due to the number of complications that can be expected a general vaccination is probably not possible. Research is ongoing to develop new vaccines. Many countries are improving their capabilities to respond to a renewed threat of a smallpox epidemic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12197872     DOI: 10.1046/j.1469-0691.2002.00525.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

Review 1.  Recent Trends in Protective Textiles against Biological Threats: A Focus on Biological Warfare Agents.

Authors:  Joana C Antunes; Inês P Moreira; Fernanda Gomes; Fernando Cunha; Mariana Henriques; Raúl Fangueiro
Journal:  Polymers (Basel)       Date:  2022-04-14       Impact factor: 4.967

2.  Vaccinia virus entry, exit, and interaction with differentiated human airway epithelia.

Authors:  Paola D Vermeer; Julia McHugh; Tatiana Rokhlina; Daniel W Vermeer; Joseph Zabner; Michael J Welsh
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

3.  Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.

Authors:  Huiyong Wei; Dan Huang; Jeff Fortman; Richard Wang; Linyun Shao; Zheng W Chen
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

4.  Detection of infectious poxvirus particles.

Authors:  Andreas Nitsche; Daniel Stern; Heinz Ellerbrok; Georg Pauli
Journal:  Emerg Infect Dis       Date:  2006-07       Impact factor: 6.883

Review 5.  SARS, avian flu, bioterror: infection control awareness for the optometrist.

Authors:  Santos Shan-Yu Tseng
Journal:  Clin Exp Optom       Date:  2007-01       Impact factor: 2.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.